Integrated Diagnostics Holdings

What Integrated Diagnostics Holdings does

Integrated Diagnostics Holdings plc is a Jersey-domiciled, London-listed (LSE: IDHC) provider of medical diagnostic services operating across five countries — Egypt, Jordan, Nigeria, Sudan, and Saudi Arabia — through a network of 724 patient service branches and a centralized Mega Lab facility in Cairo. The company operates a Hub, Spoke and Spike asset-light model that concentrates high-volume, automated testing at the CAP-certified Mega Lab (capacity 20,000 tests per hour, 3,000+ test menu) while routing sample collection through a dense branch network of trusted brands including Al Borg, Al Mokhtabar, Biolab, Ultralab, Al Borg Scan, and Echo-Lab.

IDH generates revenue primarily from per-test transaction fees for pathology and radiology services billed to walk-in patients, corporate clients, and insurance partners. The company expanded into radiology in 2018 (Al Borg Scan) and into data-driven healthcare services in 2019 (Wayak subsidiary), and most recently acquired CAIRO RAY for EGP 400 million in June 2025 to add radiotherapy capability. The technology stack combines laboratory automation (Sysmex, Siemens, GE Healthcare, Hitachi, Fujifilm equipment), a Laboratory Information Management System, and digital patient-facing tools including website and WhatsApp-based results delivery within 24 hours.

Customer segments span individual walk-in patients (8.9 million served in 2024), corporate and insurance B2B contracts, and physician referrals, with Egypt contributing approximately 84.6% of revenue. Ownership is in transition: Hena Holdings Ltd., a vehicle controlled by CEO Dr. Hend El Sherbini, consolidated approximately 49.62% control in mid-2025 following Actis/Elliott's exit, and is conducting a mandatory cash offer at USD 0.50 per share for remaining shareholders. The company is woman-led, with the CEO ranked among Forbes Middle East's Most Powerful Businesswomen from 2015 through 2023.

Name

Integrated Diagnostics Holdings

Legal name

Integrated Diagnostics Holdings plc

Website

http://www.idhcorp.com/

Company type

Public

Founded year

2008

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Integrated Diagnostics Holdings (LSE: IDHC) operates 724 diagnostic service branches across Egypt, Jordan, Nigeria, Sudan, and Saudi Arabia, serving 8.9 million patients annually through a centralized Mega Lab and trusted brands including Al Borg and Al Mokhtabar.

Ownership category

akta.pro rank

Product category

Medical Diagnostic Services

NAICS

Medical Laboratories (621511), Diagnostic Imaging Centers (621512)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Independent Diagnostic Testing Facilities (IDTFs) & Multi-Specialty Diagnostic Centers (HLAFAKAN)

akta.pro secondary industry

At-Home Lab Testing & Diagnostics-Integrated Virtual Care (HLALAAAE)

Keywords

• Medical diagnostic services
• Pathology laboratory testing
• Radiology imaging services
• Clinical diagnostics
• Diagnostic healthcare

Headquarters

HQ city

St. Helier

Offices7 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Diagnostic Testing Services: IDH generates revenue primarily from medical diagnostic testing services including pathology tests (routine and specialized) and radiology imaging services. Tests are performed at company branches and the Mega Lab facility, serving both walk-in patients and corporate/insurance clients.
2. Radiology Services: Full range of radiology services including MRI, CT, PET-CT, ultrasound, mammography, X-ray, ECG, EEG, EMG through Al Borg Scan branches.
3. Data-Driven Healthcare Services (Wayak): New subsidiary leveraging patient database for healthcare management including electronic medical records, medication home-delivery, diagnostic testing reminders, and referrals to service providers.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

Integrated Diagnostics Holdings is a fully-integrated medical diagnostics provider offering pathology laboratory testing and radiology imaging services across Egypt, Jordan, Nigeria, Sudan, and Saudi Arabia. The company operates a network of 724+ branch locations and a centralized CAP-certified Mega Lab capable of 3,000+ diagnostic tests at a throughput of 20,000 tests per hour, serving both walk-in patients and corporate/insurance clients.

Product overview

Integrated Diagnostics Holdings operates as a diversified medical diagnostics company offering a portfolio of pathology and radiology services across five countries (Egypt, Jordan, Sudan, Nigeria, and Saudi Arabia). The company operates through its core brands including Al Borg and Al Mokhtabar in Egypt, Biolab in Jordan, and provides services under Ultralab and Al Mokhtabar Sudan in Sudan and Echo-Lab in Nigeria. The portfolio includes centralized Mega Lab facilities providing over 3,000 diagnostic tests, supported by a network of 700+ branches. The company expanded into radiology services in 2018 through Al Borg Scan, and launched Wayak (data-driven healthcare subsidiary) in 2019 for AI/analytics-driven patient services. Recent additions include radiotherapy services through the acquisition of CAIRO RAY and full haematology automation via Sysmex systems.

Differentiator

Problem solved

Functional benefit

Brands

• Al Borg: Egypt's leading medical diagnostics brand with hub, spoke and spike model
• Al Mokhtabar
• Biolab
• Al Borg Scan
• Wayak

Products and services

• Mega Lab (Central Laboratory) IDH's largest fully automated central laboratory in Cairo offering 3,000+ diagnostic tests with a throughput capacity of 20,000 tests per hour. CAP-certified, housing 500+ employees including 120 highly-qualified doctors.
• Pathology Services Comprehensive diagnostic pathology services covering immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, cytogenetics, and genetics testing. Available across 724+ branches in Egypt, Jordan, Nigeria, Sudan, and Saudi Arabia.
• Radiology Services (Al Borg Scan) Full range of radiology imaging services including PET-CT, MRI, CT, mammography, ultrasound, X-ray, electromyography (EMG), electroencephalography (EEG), and electrocardiogram (ECG) through the Al Borg Scan network. ACR-accredited for nuclear medicine and ultrasound.
• Al Mokhtabar (Egypt Pathology Brand) Egypt's oldest diagnostic brand offering comprehensive pathology and molecular diagnostics services through 460+ branches across Egypt.
• Al Borg (Egypt Pathology Brand) One of IDH's primary diagnostic brands in Egypt, known for its Hub, Spoke and Spike business model, offering a comprehensive range of medical diagnostic services.
• Biolab (Jordan Diagnostic Services) IDH's Jordanian subsidiary operating 26 branches across the country, offering a complete range of laboratory and diagnostic services including specialty labs for haematology, endocrinology, immunochemistry, parasitology, oncology, transfusion medicine, molecular genetics, and antenatal diagnostics. JCI-accredited.
• Wayak (Data-Driven Healthcare Platform) Egypt-based subsidiary focused on data mining and artificial intelligence platforms that leverage a patient database of 13+ million patients to offer services including electronic medical records, patient healthcare profiles, home-delivery of medications, diagnostics testing reminders, referrals, and follow-up services.
• Echo-Lab (Nigeria Diagnostic Services) IDH's medical diagnostics brand in Nigeria offering radiology and laboratory services. Operates locations in Kaduna, Abuja, Karu, Lagos, Asaba, Benin, and Mararaba.
• CAIRO RAY Radiotherapy (Egypt) Radiology and radiotherapy facility in East Cairo, Egypt, acquired by Al Borg Scan to strengthen IDH's Egyptian radiology portfolio.

Quantifiable outcome

• 50%+ market share in Egypt's private chain diagnostics market
• +4 more outcomes

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature3 records

Partnerships

Three partnerships are on record, tiered strategic.

• Al Makhbaryoun Al Arab LLC (Biolab) and Izhoor Holding Medical CompanystrategicStrategic or Co-development Partner · 31 October 2022Joint venture agreement to launch diagnostic venture in Saudi Arabia, owned 50% by IDH Group and 50% by Izhoor (owned by Fawaz Alhokair). IDH later increased stake to 79% in December 2024.
• Airport International GroupstrategicChannel Partner/ Reseller/ Distributor · 1 August 2021Biolab (IDH's Jordanian subsidiary) selected as preferred bidder to operate PCR testing stations at Queen Alia International Airport in Amman, Jordan.
• Georgia Healthcare GroupstrategicStrategic or Co-development Partner · 17 December 2018Biolab (IDH's Jordanian subsidiary) partnered with Georgia Healthcare Group to establish a Mega Lab in Tbilisi, Georgia. Biolab provides training, management services, and LIMS implementation, retaining up to 10% equity ownership.

Scale indicators13 records

Recent moves11 records

Expansion highlights6 records

Market position

Weaknesses4 records

Competitive moat6 records

Key risks7 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries11 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Integrated Diagnostics Holdings